In a 6-month study of 86 adults, 63% of adults treated with GATTEX
reduced their weekly volume of PS by 20% or more (vs 30% with placebo). 54% of adults treated with
GATTEX achieved at least 1 day off of PS per week (vs 23% with placebo). Peggy, gattex patient
In clinical studies, GATTEX was proven to help people with SBS on PS
GATTEX reduced the weekly volume of PS.
People treated with GATTEX achieved more time off of PS.
Over time, some people achieved complete freedom from PS with GATTEX.
In a 6-month study, 27 out of 43 adults treated with GATTEX reduced weekly PS volume by 20% or more vs 13
out of 43 on placebo, and 21 out of 39 achieved at least 1 day off PS per week vs 9 out of 39 on placebo.
After 30 months of treatment, 10 out of 30 adults no longer needed PS. In a 6-month study, 18 out of 26
children treated with GATTEX reduced weekly PS volume by 20% or more, 10 out of 26 achieved a reduction of
at least 1 day off PS per week, and 3 out of 26 no longer needed PS.
Sign up to receive ongoing updates and communications about upcoming events, treatment information,
education, resources, and market research opportunities.
Please see our online privacy notice for information about our practices regarding collection, use, and disclosure of information that you may provide us.
What is GATTEX?
GATTEX® (teduglutide) for subcutaneous injection is a
prescription medicine used in adults and children 1 year of age and older
with Short Bowel Syndrome (SBS) who need additional nutrition or fluids from intravenous (IV) feeding
(parenteral support). It is not known if GATTEX is safe and effective in children under 1 year of age.
Important Safety Information
GATTEX may cause serious side effects, including making
abnormal cells grow faster, polyps in the colon (large intestine), blockage of the bowel (intestines),
swelling (inflammation) or blockage of your gallbladder or pancreas, and fluid overload. Click here for additional Important Safety Information.
Thank you! Please click the button below to download results or see the results here.
You are now leaving GATTEX.COM
You are being directed to another website. If you’d like to keep browsing, click BACK. Or, if you’d like to leave the site, click CONTINUE.